| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KCNAB3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | STAT5B | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | MYO1D | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CRLS1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CPN2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | TRIOBP | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PLA2R1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | C22orf39 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ANAPC7 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PRKAA1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
